Owens & Minor (NYSE:OMI) shares are on the rise today on first-quarter results that beat the consensus forecast. The Richmond, Virginia-based company posted profits of $29.3 million, or 52¢ per share, on sales of $2.4 billion for the three months ended March 31, 2022, for a 57.9% bottom-line slide on sales growth of 3.4%. Adjusted […]
Owens & Minor
Owens & Minor completes $1.6B acquisition of Apria
Owens & Minor (NYSE:OMI) announced today that it closed its previously announced $1.6 billion acquisition of Apria. The Richmond, Virginia-based company previously announced the planned acquisition of Apria, a developer of home medical equipment for respiratory therapy, sleep apnea treatment, negative pressure wound therapy, and continuous glucose monitoring, in January 2022. According to a news […]
Owens & Minor launches $500M senior note offering
Owens & Minor (NYSE:OMI) announced today that it launched a private offering worth $500 million in senior notes. Richmond, Virginia-based Owens & Minor’s notes — due in 2030 — will provide proceeds to finance the company’s acquisition of Apria. According to a news release, unless the acquisition is consummated concurrently with or promptly following the […]
Owens & Minor ticks up on Street-beating Q4 results
Owens & Minor (NYSE:OMI) today posted fourth-quarter results that beat the overall consensus on Wall Street. The Richmond, Virginia-based orthopedic device company reported profits of $41.97 million, or 55¢ per share, on sales of $2.5 billion for the three months ended Dec. 31, 2021, for a bottom-line loss of -17.3% on sales growth of 4.46% […]
Owens & Minor to acquire Apria for $1.5B
Owens & Minor today announced that it has signed a definitive agreement to acquire Apria for $1.45 billion. Apria provides home medical equipment for respiratory therapy, sleep apnea treatment, negative pressure wound therapy, and continuous glucose monitoring. The acquisition will supplement Owens & Minor’s Patient Direct portfolio of diabetes, ostomy, incontinence and wound care. “I’m […]
Owens & Minor beats the Street in Q3, narrows full-year guidance
Owens & Minor (NYSE:OMI) shares hardly budged today on third-quarter results that topped the consensus forecast. The Richmond, Virginia-based company posted profits of $44.1 million, or 48¢ per share, on sales of just over $2.5 billion for the three months ended Sept. 30, 2021, for a 4.3% bottom-line slide on sales growth of 14.4%. Adjusted […]
Owens & Minor down — even with Street-beating Q2 results
Owens & Minor (NYSE:OMI) posted second-quarter financial results today that beat the overall consensus on Wall Street. Shares in OMI, however, were down more than –10% to $42.13 apiece in morning trading. MassDevice‘s MedTech 100 Index, which includes stocks of the world’s largest medical device companies, was down slightly. The Richmond, Va.–based company reported profits of […]
Owens & Minor ticks up in pre-market trading on mixed Q1 results
Owens & Minor (NYSE:OMI) posted first-quarter results today that missed the consensus on Wall Street but raised its full-year guidance range for adjusted net income. The Richmond, Va.-based company reported profits of $69.589 million, or 98¢ per share, on sales of $2.327 billion for the three months ended March 31, for a sales growth of 9.61% […]
8 medical device companies that beat the COVID-19 pandemic and prospered
Some medical device businesses not only survived the COVID-19 pandemic but actually thrived — with many producing the medtech needed to fight the coronavirus’s spread. Medical Design & Outsourcing recently analyzed financials for 20 of the largest medical device businesses in the world. Not only was revenue only slightly down for the 20 during 2020, but it was […]
How big medtech fared during a year of COVID-19
Despite numerous challenges, the medtech industry showed itself to be fairly recession-proof in 2020, according to a Medical Design & Outsourcing/MassDevice analysis of financials. Annual reports recently released by 20 of the world’s largest medical device companies showed only a slight dip in revenue during 2020 — a year in which medtech held the front lines against […]
The top 7 medtech CEO quotes on COVID-19, one year later
The latest earnings season has provided insights into the future of medtech in the COVID-19 landscape and what certain sectors are seeing as vaccines start to roll out. Since the start of the pandemic, 113.1 million COVID-19 cases have been reported worldwide, according to Johns Hopkins University School of Medicine. The U.S. leads the world […]
